Hyperimmune Globulins Market

Hyperimmune globulin is similar to intravenous immunoglobulin (IVIG) except that it is prepared from the plasma of donors with high titers of antibody against a specific organism or antigen. Some agents against which hyperimmune globulins are available include hepatitis B, rabies, tetanus toxin, varicella-zoster, etc. Administration of hyperimmune globulin provides "passive" immunity to the patient against an agent. This is in contrast to vaccines that provide "active" immunity. However, vaccines take much longer to achieve that purpose while hyperimmune globulin provides instant "passive" short-lived immunity. Hyperimmune globulin may have serious side effects, thus usage is taken very seriously.
Hyperimmune globulin is prepared from the plasma of donors with high titers of antibody against a specific organism or antigen. Some agents against which hyperimmune globulins are available include hepatitis B, rabies, tetanus toxin, varicella-zoster, etc. Administration of hyperimmune globulin provides "passive" immunity to the patient against an agent. Hyperimmune globulin may have serious side effects, thus usage is taken very seriously.
Hyperimmune Globulins Market aims to provide a comprehensive presentation of the global market for Hyperimmune Globulins, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hyperimmune Globulins. Hyperimmune Globulins Market contains market size and forecasts of Hyperimmune Globulins in global, including the following market information:
Global Hyperimmune Globulins Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Hyperimmune Globulins Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Hyperimmune Globulins companies in 2022 (%)
The global Hyperimmune Globulins market was valued at US$ 1742 million in 2022 and is projected to reach US$ 2742.7 million by 2029, at a CAGR of 6.7% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Hyperimmune Globulins key players include CSL Behring, Grifols, etc. Global top two manufacturers hold a share over 50%.
Asia-Pacific is the largest market, with a share about 30%, followed by Europe and North America, both have a share over 50 percent.
In terms of product, Rho(D) Immunoglobulins is the largest segment, with a share about 33%. And in terms of application, the largest application is Government Institution, followed by Private Sector, etc.
We surveyed the Hyperimmune Globulins manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hyperimmune Globulins Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Hyperimmune Globulins Market Segment Percentages, by Type, 2022 (%)
Hepatitis B Immunoglobulins
Rabies Immunoglobulins
Tetanus Immunoglobulins
Rho(D) Immunoglobulins
Other
Global Hyperimmune Globulins Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Hyperimmune Globulins Market Segment Percentages, by Application, 2022 (%)
Government Institutions
Private Sector
Other
Global Hyperimmune Globulins Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Hyperimmune Globulins Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hyperimmune Globulins revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Hyperimmune Globulins revenues share in global market, 2022 (%)
Key companies Hyperimmune Globulins sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Hyperimmune Globulins sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
CSL Behring
Grifols
Biotest
Kedrion
CBPO
Emergent (Cangene)
Kamada
CNBG
Hualan Bio
Shanghai RAAS
Sichuan Yuanda Shuyang
ADMA Biologics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Hyperimmune Globulins, market overview.
Chapter 2: Global Hyperimmune Globulins market size in revenue and volume.
Chapter 3: Detailed analysis of Hyperimmune Globulins manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Hyperimmune Globulins in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Hyperimmune Globulins capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.